Login / Signup
GLP-1 Receptor Agonists and SGLT-2 Inhibitors as Adjuncts to Insulin in Type 1 Diabetes: Benefits and Concerns.
George D Dimitriadis
Vaia Lambadiari
Published in:
The Journal of clinical endocrinology and metabolism (2023)
Keyphrases
</>
type diabetes
glycemic control
cardiovascular disease
insulin resistance
adipose tissue